This is a summary of the European public assessment report (EPAR) for DuoTrav. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for DuoTrav.
Therapeutic Indication
### Therapeutic indication Decrease of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
Therapeutic Area (MeSH)
ATC Code
S01ED51
ATC Item
timolol, combinations
Pharmacotherapeutic Group
Ophthalmologicals
Active Substance (Summary)
INN / Common Names
EMA Name
DuoTrav
Medicine Name
DuoTrav
Aliases
N/ANo risk management plan link.
